mrd detection in myeloma: approval of ngs assay & questions for the clinic
Published 5 years ago • 188 plays • Length 3:19Download video MP4
Download video MP3
Similar videos
-
2:15
mass spectrometry, ngs & ngf for mrd detection in multiple myeloma
-
1:05
clonotypic mass spectrometry with easym assay for mrd detection in multiple myeloma
-
0:59
opinion: mrd sequencing test approval in multiple myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
1:23
combining mrd assays with functional imaging in multiple myeloma
-
1:59
methods used to assess mrd status in multiple myeloma
-
0:45
how risk assessment in myeloma is changing with the emergence of mrd
-
2:31
determining the optimal threshold to test mrd in multiple myeloma
-
49:36
experience with mm mrd in our clinical laboratory: theory and practice
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
3:07
minimal residual disease (mrd)
-
1:18
how next-generation sequencing will change the treatment of multiple myeloma
-
2:00
advancing mrd monitoring in myeloma
-
2:00
mrd detection with ngs for aml: a new era of diagnostics
-
1:37
using validated next-generation techniques for monitoring mrd in multiple myeloma
-
1:20
mrd in myeloma
-
2:55
multiple myeloma mrd assessment
-
2:57
when is the optimal time to measure minimal residual disease (mrd) in myeloma patients?
-
1:22
an all-molecular diagnostic approach for myeloma
-
2:27
mrd by mass spectrometry in the peripheral blood in myeloma
-
1:46
forte: mrd by mfc or ngs in myeloma
-
2:17
mrd: a promising biomarker in multiple myeloma